ASX Share rice
Sat 15 May 2021 - 02:52:am (Sydney)

BIT Share Price

BIOTRON LIMITEDBITPharmaceuticals, Biotechnology & Life Sciences

BIT Company Information

Name:

Biotron Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

56 Delhi Road North Ryde NSW Australia 2113

Phone:

61 2 9805 0488

CEO, MD & Exec. Director:

Dr. Michelle Miller BSc., GCertAppFin, Ph.D., MSc.

Company Sec.:

Mr. Peter James Nightingale B.Econ, CA

Chief Medical Officer:

Dr. Stephen L. Becker M.D.

Company Overview:

Biotron Limited, a biotechnology company, engages in the developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also develops a portfolio of preclinical antiviral drugs. Biotron Limited was incorporated in 1999 and is based in North Ryde, Australia.

BIT Share Price Information

Shares Issued:

701.93M

Market Capitalisation:

$37.90M

Revenue (TTM):

$853.03K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.003

Operating Margin (TTM):

$-4.61

Return On Assets (TTM):

$-0.35

Return On Equity (TTM):

$-0.60

Quarterly Revenue Growth (YOY):

-1

Gross Profit(TTM):

$803.03K

Diluted Earnings Per Share (TTM):

$-0.006

BIT CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$123.65K

Net Borrowings:

$-32,979

Net Income:

$-3,575,959

Total Cash From Operating Activities:

$-3,081,822

Depreciation:

$50.12K

Sale Purchase Of Stock:

$5.31M

Capital Expenditures:

$0

BIT Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,575,960

Net Income:

$-3,575,960

Gross Profit:

$-2,054,350

Operating Income:

$-3,640,170

Other Operating Expenses:

$394.67K

Interest Expense:

$5.12K

Total Revenue:

$803.03K

Cost Of Revenue:

$2.86M

BIT Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$853.19K

Total Stockholder Equity:

$6.97M

Total Assets:

$7.83M

Common Stock:

$52.84M

Retained Earnings:

$-45,945,067

Other Liabilities:

$9.13K

Other Assets:

$33.86K

Cash:

$7.66M

Total Current Liabilities:

$840.76K

Property - Plant & Equipment:

$73.20K

Net Tangible Assets:

$6.97M

Long-Term Investments:

$33.86K

Total Current Assets:

$7.72M

Short-Term Investments:

$107.06K

Accounts Payable:

$309.99K

Non Currrent Assets (Other):

$33.86K

Short-Term Investments:

$107.06

Non Current Liabilities Total:

$12.44K

BIT Share Price History

BIT News

03 Dec, 2020
The CEO of Biotron Limited ( ASX:BIT ) is Michelle Miller, and this article examines the executive's compensation...
04 Sep, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
22 May, 2020
We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...